POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
Biotechnology
Website
Company Tagline
Accelerating Precision Medicine™
Industry Category
Business Keywords
Company Description
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, is dedicated to accelerating precision medicine through the development of next-generation radioligand therapies for the treatment of cancer. Based in Indianapolis, Indiana, POINT Biopharma is committed to innovation in oncology and radiopharmaceuticals. Their focus on radioligand technology positions them as a key player in the future of cancer treatment.
Located at 4850 W 78th St, Indianapolis, Indiana 46268, US, POINT Biopharma aims to improve patient outcomes through targeted therapies. The company's expertise in radioligands allows for precise and effective cancer treatment, reflecting their dedication to advancing medical science and patient care.
POINT Biopharma's work significantly contributes to the biotechnology and pharmaceutical sectors, driving progress in oncology treatments. We invite the management team at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, to further enhance their company's profile by creating a customized and exclusive company showcase and product listing on our platform.
POINT Biopharma, filiale en propriété exclusive d'Eli Lilly and Company, se consacre à l'accélération de la médecine de précision grâce au développement de thérapies radioligandes de nouvelle génération pour le traitement du cancer. Basée à Indianapolis, dans l'Indiana, POINT Biopharma s'engage à innover dans les domaines de l'oncologie et des produits radiopharmaceutiques. Leur concentration sur la technologie des radioligandes les positionne comme un acteur clé dans l'avenir du traitement du cancer.
Située au 4850 W 78th St, Indianapolis, Indiana 46268, États-Unis, POINT Biopharma vise à améliorer les résultats pour les patients grâce à des thérapies ciblées. L'expertise de l'entreprise en matière de radioligandes permet un traitement précis et efficace du cancer, reflétant son engagement à faire progresser la science médicale et les soins aux patients.
Le travail de POINT Biopharma contribue de manière significative aux secteurs de la biotechnologie et de la pharmacie, stimulant les progrès dans les traitements oncologiques. Nous invitons l'équipe de direction de POINT Biopharma, filiale en propriété exclusive d'Eli Lilly and Company, à améliorer davantage le profil de leur entreprise en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company with 3 companies in Biotechnology
| Comparison Field |
POINT Biopharma, a wholly...Main Company |
Children's HealthView Profile |
BOPA (The British On...View Profile |
Medneon (Acquired by...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1913 | 1996 | 2018 |
|
Company Size
|
— | 5,001-10,000 | 51-200 | 11-50 |
|
City
|
Indianapolis, Indiana | Dallas, TX | Cupertino, CA | |
|
Country
|
United States | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Radioligand Therapy
Precision Medicine
Oncology
Radiopharmaceuticals
Biotechnology
Cancer Treatment
Targeted Therapies
Radioligand
Cancer
Radiopharmaceutical
|
13 Total
13 Unique
Unique Skills:
Cardiology
Endocrinology
Gastrointestinal
GI
Heart
Neonatal
+7
|
4 Total
4 Unique
Unique Skills:
Pharmacist
Pharmacy
Treatment
UK
|
17 Total
17 Unique
Unique Skills:
Artificial Intelligence
Breast Cancer
Clinical Insights
Data Science
DNA
Genetic Insights
+11
|
4
Total Companies1913
Oldest Founded1
Countries44
Unique SkillsSimilar Companies
Other organizations in the same industry
Shimadzu Scientific Instruments
BiotechnologyProviding innovative, proven products for a wide range of laboratories and applications
Alithia Life Sciences
BiotechnologyAlithia Life Sciences, a clinical research consultancy supporting companies with their project in Au...
Altis Biosystems
BiotechnologyCapturing the Complexity of the Human Gut
Alternative Company Names
This company is also known as